CLL and Non-Hodgkin Lymphoma, What are the risks and benefits of both ibrutinib and Idelalisib

CLL and Non-Hodgkin Lymphoma, What are the risks and benefits of both ibrutinib and Idelalisib

cancergrace

4 months
123 Views
Share
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
CLL and non-hodgkin lymphoma, What are the risks and benefits of both ibrutinib and Idelalisib
Up Next Autoplay
Observations from PROVe Study #EORTC2019
Observations from PROVe Study #EORTC2019
Category: Non-Hodgkin Lymphoma
27 Views
Cancer-News 1 month
PROVe Study: How Long Are Patients On Therapy? #EORTC2019
PROVe Study: How Long Are Patients On Therapy? #EORTC2019
Category: Non-Hodgkin Lymphoma
14 Views
Cancer-News 1 month
PROVe study: Treatment of MF-CTCL Patients #EORTC2019
PROVe study: Treatment of MF-CTCL Patients #EORTC2019
Category: Non-Hodgkin Lymphoma
18 Views
Cancer-News 1 month
Verastem Oncology Receives Orphan Drug Designation from FDA for COPIKTRA for the Treatment of T-Cell Lymphoma
Verastem Oncology Receives Orphan Drug Designation from FDA for COPIKTRA for the Treatment of T-Cell Lymphoma
Category: Non-Hodgkin Lymphoma
14 Views
Cancer-News 1 month
CLL and Non-Hodgkin Lymphoma, What new drugs are on the horizon and why are they exciting
CLL and Non-Hodgkin Lymphoma, What new drugs are on the horizon and why are they exciting
Category: Non-Hodgkin Lymphoma
231 Views
cancergrace 4 months
Chronic Lymphocytic Leukemia,  Non-Hodgkin Lymphoma, Should all HL patients be treated the same
Chronic Lymphocytic Leukemia, Non-Hodgkin Lymphoma, Should all HL patients be treated the same
Category: Non-Hodgkin Lymphoma
115 Views
cancergrace 4 months
The Clinical Study Investigating Mosunetuzumab
The Clinical Study Investigating Mosunetuzumab
Category: Non-Hodgkin Lymphoma
110 Views
obr 10 months
Results Of The AUGMENT Study In Relapsed/Refractory Indolent NHL
Results Of The AUGMENT Study In Relapsed/Refractory Indolent NHL
Category: Non-Hodgkin Lymphoma
47 Views
obr 10 months
Non-hodgkin lymphoma advances in 2018
Non-hodgkin lymphoma advances in 2018
Category: Non-Hodgkin Lymphoma
178 Views
VJHemOnc 1 year